Heparan-sulfate-modified proteins, or proteoglycans (HSPGs), may be a useful early-stage target for novel treatments for Alzheimer’s disease, according to research led by Pennsylvania State University. Up to seven million Americans suffer with Alzheimer’s disease, a neurological condition that is steadily on the rise. The majority of these patients are over 65. While many late-stage trials […]
Continue Reading
The crucial role that the protein Contactin-4, which is produced by the gene CNTN4, plays in forming neurons has been identified by a recent study headed by the University of Exeter and published in Open Biology. Although CNTN4 was recognized to have a part in autism, its functional roles were unclear, which is why the […]
Continue Reading
It looks like scientists have discovered a new way to combat Alzheimer’s. According to a new study, the accumulation of fat droplets within brain cells may be the primary culprit. According to Michael Haney of the University of Pennsylvania, therapies that specifically target these droplets may prove to be more successful. “This opens up a […]
Continue Reading
In the event that you’re inexperienced with the expression “gentle mental disability,” you’re not alone. Over 80% of Americans aren’t acquainted with this condition that effects up to 18% of individuals ages 60 and more seasoned and can prompt Alzheimer’s sickness, another study has found. Another report gauges 6.5 million Americans have Alzheimer’s infection and […]
Continue Reading